 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 1303
H.P. 900 House of  Representatives,  April 4, 2017
An Act  To Establish the Vaccine  Consumer Protection Program  
within the  Department of Health and  Human Services
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative O'CONNOR of Berwick.
Cosponsored by Representatives:  SANDERSON  of Chelsea, SIROCKI  of Scarborough.

 
 Page 1 - 128LR1733(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  20-A MRSA §6353, sub -§3, as amended by PL 2001, c. 326, §1, is 2 
further amended to read:  3 
3.  Disease.   "Disease" means those conditions that are preventable by immunizing 4 
agent , as speci fied in rules . 5 
Sec. 2.  20-A MRSA §6355, sub -§2, as amended by PL 2001, c. 326, §2, is 6 
further amended to read:  7 
2.  Medical exemption.  The parent or the child provides a physician's written 8 
statement that immunization against one or more of the diseases m ay be medically 9 
inadvisable as determined by the physician . 10 
Sec. 3.  20-A MRSA §6357, sub -§2, as enacted by PL 1983, c. 661, §8 and 11 
amended by PL 2003, c. 689, Pt. B, §6, is further amended to read:  12 
2.  Annual report of immunization status.   By December 15 th of each year, each 13 
superintendent shall submit to the Director of the Bureau of Health, Department of Health 14 
and Human Services, and to the commissioner a summary report of immunization status 15 
of the children entering school , as prescribed by rule . 16 
Sec. 4.  20-A MRSA §6358, as amended by PL 2001, c. 326, §3 and PL 2003, c. 17 
689, Pt. B, §6, is repealed.  18 
Sec. 5.  20-A MRSA §6359, sub -§1, ¶C, as amended by PL 2001, c. 326, §4, is 19 
further amended to read:  20 
C.  "Disease" means those conditions that are preventa ble by immunizing agent , as 21 
specified in rules . 22 
Sec. 6.  20-A MRSA §6359, sub -§2, as amended by PL 2001, c. 326, §5 and PL 23 
2003, c. 689, Pt. B, §6, is further amended to read:  24 
2.  Immunization.   Except as otherwise provided under this section, every studen t 25 
shall have  must be  administered an adequate dosage of an immunizing agent against each 26 
disease as specified by rule . 27 
Any such immunizing agent shall  must  meet standards for the biological products, 28 
approved by the United States Public Health Service and the dosage requirement 29 
specified by the Department of Health and Human Services.  30 
Sec. 7.  20-A MRSA §6359, sub -§5, as enacted by PL 1985, c. 771, §§2 and 7, is 31 
amended to read:  32 
5.  Records; report.   Each chief administrative officer shall keep uniform reco rds of 33 
the immunizations and immunization status of each student, based on the certificate of 34 
immunization, other acceptable evidence and other available documents.  The records 35 
shall  must  be part of the student's permanent records.  36 
 
 Page 2 - 128LR1733(01) -1 
 By December 15th of eac h year, each chief administrative officer shall submit to the 1 
Director of the Bureau of Health a summary report of immunization status of the students 2 
entering school , as prescribed by rule .  A blank summary report form will must  be 3 
provided to each chief administrative officer by the Bureau of Health.  4 
Sec. 8.  20-A MRSA §6359, sub -§6, as amended by PL 1991, c. 146, §4, is 5 
repealed.  6 
Sec. 9.  22 MRSA §1067 is enacted to read:  7 
§1067.  Vaccine Consumer Protection Program  8 
1.  Definitions.  As used in this secti on, unless the context otherwise indicates, the 9 
following terms have the following meanings.  10 
A.  "Health care provider" means a physician, nurse, clinic, hospital or other entity 11 
licensed by this State to provide health care services that administers vacci nes. 12 
B.  "Office" means the Vaccine Consumer Protection Office established in this 13 
section.  14 
C.  "Program" means the Vaccine Consumer Protection Program established in this 15 
section.  16 
D.  "Vaccine injury table" means the vaccine injury table of covered vaccin es and 17 
associated injuries established by 42 Code of Federal Regulations, Section 100.3 18 
(2000).  19 
2.  Program and office established.  The Vaccine Consumer Protection Program is 20 
established within the department.  The Vaccine Consumer Protection Office is 21 
established within the department to carry out the purposes of the program.  22 
3.  Services.  Under the program, the office shall provide information about vaccine 23 
injuries and immunizations to health care providers and the public.  24 
The office shall establish an d implement procedures to:  25 
A.  Promote public awareness of the vaccine injury table through development and 26 
implementation of an educational outreach program that provides, at a minimum, the 27 
information contained in the vaccine injury table to any individu al in the State who 28 
requests information related to vaccine injuries or immunizations;  29 
B.  Educate health care providers on the contents of the vaccine injury table to help 30 
providers better screen for and diagnose adverse events caused by vaccines;  31 
C.  Require health care providers to use vaccine package inserts that describe the 32 
warnings, precautions and adverse reactions potentially caused by a particular 33 
vaccine during the screening and diagnosing of an illness, disability, injury or adverse 34 
condition ca used by vaccines;  35 
D.  Write and publicize a vaccine information statement.  The statement must include 36 
evidence -based information about vaccines and their potentially adverse side effects, 37 
inform patients about their right to opt out of vaccine requirement s based on religious 38 
 
 Page 3 - 128LR1733(01) -1 
 and philosophical grounds and offer a step -by-step explanation about how to pursue 1 
legal recourse if an individual suspects a vaccine injury has occurred.  When drafting 2 
the statement, the department shall consult with nationally recog nized vaccine safety 3 
advocates and the families of children in the State who have been injured by 4 
vaccines;  5 
E.  Investigate potential vaccine injuries;  6 
F.  Evaluate vaccine injury claims;  7 
G.  Review instances of potential coercion by health care providers related to the 8 
issuance of a vaccine and require health care providers who are suspected of coercion 9 
to retract any inaccurate statements or face discipline by the applicable professional 10 
licensing entity;  11 
H.  Educate health care providers about the proces ses for handling vaccine injury 12 
claims that are brought against their practice;  13 
I.  Provide individuals with referrals to health care providers that treat vaccine 14 
injuries and to attorneys that handle claims related to vaccine injuries; and  15 
J.  Recoup fund s that are spent on vaccine injury cases under the MaineCare program 16 
established under chapter 855.  17 
4.  Rules.  The department shall adopt rules to implement this section.  Rules adopted 18 
pursuant to this subsection are major substantive rules pursuant to T itle 5, chapter 375, 19 
subchapter 2 -A. 20 
5.  Repeal.  Upon the repeal of the National Childhood Vaccine Injury Act of 1986, 21 
42 United States Code, Sections 300aa -1 to 300aa -34, the department shall submit 22 
legislation repealing this section.  23 
Sec. 10.  Reference  manual.  The Department of Health and Human Services 24 
shall add the vaccine injury table of covered vaccines and associated injuries established 25 
by 42 Code of Federal Regulations, Section 100.3 (2000) to the Maine Immunization 26 
Program's Provider Reference Manual created by the department's division of infectious 27 
disease within the Maine Center for Disease Control and Prevention.  28 
SUMMARY  29 
This bill establishes the Vaccine Consumer Protection Program within the 30 
Department of Health and Human Services and descr ibes the services provided under the 31 
program.  This bill also clarifies that a medical exemption from immunization for the 32 
purposes of school attendance is to be determined by the child's physician.  This bill also 33 
removes the Commissioner of Education and  the Department of Health and Human 34 
Services rule -making authority regarding the statutory immunization provisions and 35 
school and municipal authority to have more stringent immunization requirements than 36 
state law.  37 
 
